Antibodies specific for human prostate glandular kallkrein
US5516639A · kind A · utility
33Cited by
20References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 22, 1993 |
| Grant date | May 14, 1996 |
| Priority date | — |
| Expiry date | Jul 22, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S436/813
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention provides an isolated preparation of monoclonal or polyclonal antibodies which react specifically with human prostate-specific glandular kallikrein (hK2), but which do not cross-react with human prostate-specific antigen (PSA), as well as immunogenic hK2 antigens useful to provide such antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.